Literature DB >> 12203036

The effect of active absorbable algal calcium (AAA Ca) with collagen and other matrix components on back and joint pain and skin impedance.

Takuo Fujita1, Mutsumi Ohue, Yoshio Fujii, Akimitsu Miyauchi, Yasuyuki Takagi.   

Abstract

The effect of active absorbable algal calcium (AAA Ca) with collagen and other matrix components on aging-associated skin changes and backache and joint pain was tested in a case-controlled study of 40 test subjects and 40 age-matched control subjects (mean age, 65 years) complaining of backache and knee joint pain due to osteoarthritis, spondylosis deformans, and/or osteoporosis. Supplementation with 900 mg calcium (given as AAA Ca) and 3.5 g collagen and other matrix components, including glucosamine, daily for 4 months resulted in a marked alleviation of subjective pain, assessed by the face scale. A fall of skin impedance in response to exercise loads, such as standing up, walking, squatting, and climbing up and down stairs, reported as an objective manifestion of pain, was also alleviated. The basal skin impedance, which increases with age, was significantly reduced in response to the Ca-collagen-matrix supplementation, suggesting a change of skin properties similar to rejuvenation, along with subjective smoothening and moistening of the skin. Urinary excretion of N-terminal crosslinking telopeptide of type I collagen (NTx) was decreased in the Ca-collagen-matrix supplementation group, but not in the control group. In addition to calcium suppression of parathyroid hormone, preventing bone resorption, collagen, acting on the intestinal lymphatic system, may protect collagen from degradation through the inhibition of cytokine-induced release of metalloproteinases, including collagenase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203036     DOI: 10.1007/s007740200043

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  7 in total

1.  DNA methylation and mRNA expression of COL6A3 in antler mesenchyme of female and male reindeer.

Authors:  Jian-Cheng Zhai; Ruo-Bing Han; Sheng-Nan Wang; Qiang-Hui Wang; Yan-Ling Xia; Wei-Shi Liu; Ya-Jie Yin; He-Ping Li
Journal:  Genes Genomics       Date:  2019-05-27       Impact factor: 1.839

Review 2.  Chondroitin for osteoarthritis.

Authors:  Jasvinder A Singh; Shahrzad Noorbaloochi; Roderick MacDonald; Lara J Maxwell
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

3.  Analgesic effect of raloxifene on back and knee pain in postmenopausal women with osteoporosis and/or osteoarthritis.

Authors:  Takuo Fujita; Yoshio Fujii; Hiromi Munezane; Mutsumi Ohue; Yasuyuki Takagi
Journal:  J Bone Miner Metab       Date:  2010-02-16       Impact factor: 2.626

4.  Efficacy of glucosamine, chondroitin, and methylsulfonylmethane for spinal degenerative joint disease and degenerative disc disease: a systematic review.

Authors:  Kent Stuber; Sandy Sajko; Kevyn Kristmanson
Journal:  J Can Chiropr Assoc       Date:  2011-03

5.  Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance.

Authors:  Takuo Fujita; Mutsumi Ohue; Yoshio Fujii; Akimitsu Miyauchi; Yasuyuki Takagi
Journal:  J Bone Miner Metab       Date:  2009-02-13       Impact factor: 2.626

6.  Marine Collagen Hydrolysates Promote Collagen Synthesis, Viability and Proliferation While Downregulating the Synthesis of Pro-Catabolic Markers in Human Articular Chondrocytes.

Authors:  Bastien Bourdon; Frédéric Cassé; Nicolas Gruchy; Pierre Cambier; Sylvain Leclercq; Sarah Oddoux; Antoine Noël; Jérôme E Lafont; Romain Contentin; Philippe Galéra
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

7.  Sika Deer Antler Collagen Type I-Accelerated Osteogenesis in Bone Marrow Mesenchymal Stem Cells via the Smad Pathway.

Authors:  Na Li; Min Zhang; Gregor P C Drummen; Yu Zhao; Yin Fen Tan; Su Luo; Xiao Bo Qu
Journal:  Evid Based Complement Alternat Med       Date:  2016-01-04       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.